Acetyl-L-carnitine

N/A

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameAcetyl-L-carnitine
Drug Alias Name乙酰左旋肉碱LevacecarnineL-乙酰基肉碱L-acetylcarnitineLevocarnitine acetyl +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarnitine acetylase stimulants
TargetsCarnitine acetylase
Therapy Area/IndicationsDiabetic peripheral neuropathyChemotherapy induced poisoningBipolar Disorder +[31] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A

Develop Information

Active CompaniesCairo UniversityBrown UniversityMario Negri Institute For Pharmacological Research +[4] 
Inactive CompaniesUniversity Of AlbertaSigma-Tau Research IncIndiana University +[8] 
Active IndicationsDiabetic peripheral neuropathyAlcoholismDiabetic Neuropathies +[9] 
Inactive IndicationsChemotherapy induced poisoningBipolar DisorderOccupational Stress +[22] 

Other Information

ATC CodeN06BX12
Related LinksWikipedia